Both body creams and lotions hydrate skin, but they have a few key differences. The main is consistency. Here’s how to tell ...

and mupirocin ointment. Patch testing with the North American Contact Dermatitis Group (NACDG) standard tray, corticosteroids, vehicles, preservatives, flavorings, corticosteroids, cosmetics ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...

If you can already feel the moisture-sucking wind of the winter ahead, now is the time to drop this all-purpose salve into ...

Foot creams can moisturize the skin and act as a treatment for common foot concerns, including calluses, blisters and more.

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

A 67-year-old patient with a personal history of systemic scleroderma and chronic renal failure and who had been in hemodialysis since 2004 presented with an itchy, erythematous, and desquamative ...

Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older Organon (NYSE: OGN), a global healthcare company with a ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

cream, 1% as a treatment for atopic dermatitis (AD) in adults and children two years of age and older. The new target date is March 12, 2025, revised from the original target action date of ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.